Functional and molecular imaging of localized and recurrent prostate cancer. (Q38104639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Functional and molecular imaging of localized and recurrent prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

8

Baris Turkbey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

Peter L Choyke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

Marcelino Bernardo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

Yuxi Pang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

Haytham Shebel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

Harsh K Agarwal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

Kinzya Grant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Maria L Lindenberg

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

7 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

40 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

S48-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

ESUR prostate MR guidelines 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Multiparametric MRI and prostate cancer diagnosis and risk stratification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

MR imaging of treated prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

An Exploratory Study of Endorectal Magnetic Resonance Imaging and Spectroscopy of the Prostate as Preoperative Predictive Biomarkers of Biochemical Relapse After Radical Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Introducing parametric fusion PET/MRI of primary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Computed diffusion-weighted MR imaging may improve tumor detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2419-6

Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma

21 January 2018

1 reference

12 December 2020

Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 Tesla: should we use an endorectal coil?

1 reference

12 December 2020

Inability of refined CT to assess local extent of prostatic cancer

1 reference

12 December 2020

MRI of localized prostate cancer: coming of age in the PSA era

1 reference

12 December 2020

Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Localization of Recurrent Prostate Cancer After External Beam Radiotherapy

1 reference

12 December 2020

Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy

1 reference

12 December 2020

In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil

1 reference

12 December 2020

Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging

1 reference

12 December 2020

Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging

1 reference

12 December 2020

Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR)

1 reference

12 December 2020

PET imaging of prostate cancer using carbon-11-choline.

1 reference

12 December 2020

Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer.

1 reference

12 December 2020

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

1 reference

12 December 2020

Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis

1 reference

12 December 2020

10.1007/S00259-013-2419-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649462%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

23649462

1 reference